Sulfasalazine is generally well tolerated and, unlike mesalazine, is not commonly associated with renal complications
In summary, sulfasalazine-induced nephrolithiasis is an uncommon but potentially under-recognized complication of sulfasalazine therapy that should be considered in any
A 56-year-old woman with a 35-year history of ulcerative colitis (UC) and recurrent kidney stones that had been in remission since 1995 on sulfasalazine 1000
Sulfapyridine moiety is thought to be responsible for most of the side effects of sulfasalazine treatment, which can be managed by dose adjustment in the majority of
Two men with longstanding ulcerative colitis who were treated with sulphasalazine for several years and who developed chronic renal failure are reported
About half of the patients treated with sulfasalazine showed clinical improvements by a validated measure of disease severity, whereas fewer than 10